Evidence map›Paper›PMID 33398051›Full record

ArticleNPJ Parkinson's disease2021

Interdependence of metals and its binding proteins in Parkinson's disease for diagnosis.

Athira Anirudhan, Paramasivam Prabu, Jaya Sanyal, Tapas Kumar Banerjee, Gautam Guha, Ram Murugesan, Shiek S S J Ahmed

Open access · goldAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Athira AnirudhanFaculty of Allied Health Sciences, Chettinad Academy of Research and Education CARE, Kelambakkam, 603103, India.
Paramasivam PrabuSchool of Medicine, Department of Neurology, University of New Mexico Health Sciences Center, University of New Mexico, New Mexico, USA.
Jaya SanyalDepartment of Anthropology, University of Delhi, Delhi, 110007, India.
Tapas Kumar BanerjeeDepartment of Neurology, National Neurosciences Centre, Kolkata, India.
Gautam GuhaDepartment of Neurology, Nil Ratan Sircar Medical College and Hospital, Kolkata, India.
Ram MurugesanDrug Discovery & Omics Lab, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Kelambakkam, 603103, India.
Shiek S S J AhmedDrug Discovery & Omics Lab, Faculty of Allied Health Sciences, Chettinad Academy of Research and Education, Kelambakkam, 603103, India. shiekssjahmed@gmail.com.
Chettinad Academy of Research and Education · INMedical College and Hospital, Kolkata · INNational Neurosciences Centre · INUniversity of Delhi · INUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metalloproteins utilizes cellular metals which plays a crucial function in brain that linked with neurodegenerative disorders. Parkinson's disease (PD) is a neurodegenerative disorder that affects geriatric population world-wide. Twenty-four metal-binding protein networks were investigated to identify key regulating protein hubs in PD blood and brain. Amongst, aluminum, calcium, copper, iron, and magnesium protein hubs are the key regulators showing the ability to classify PD from control based on thirty-four classification algorithms. Analysis of these five metal proteins hubs showed involvement in environmental information processing, immune, neuronal, endocrine, aging, and signal transduction pathways. Furthermore, gene expression of functional protein in each hub showed significant upregulation of EFEMP2, MMP9, B2M, MEAF2A, and TARDBP in PD. Dysregulating hub proteins imprint the metal availability in a biological system. Hence, metal concentration in serum and cerebrospinal fluid were tested, which were altered and showed significant contribution towards gene expression of metal hub proteins along with the previously reported PD markers. In conclusion, analyzing the levels of serum metals along with the gene expression in PD opens up an ideal and feasible diagnostic intervention for PD. Hence, this will be a cost effective and rapid method for the detection of Parkinson's disease.

Identifiers

PMID33398051
PMCPMC7782529
OpenAlexW3120953963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.